Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio
Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio · Investor's Business Daily

In This Article:

Alnylam stock jumped Friday after the drugmaker won a second Food and Drug Administration approval for its drug, Amvuttra.